Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel steroid compounds demonstrate anticancer potential

Dec. 27, 2000

SLIL designs conformationally restricted polyamine analogues for cancer therapy

Dec. 27, 2000

New oncolytic drugs from Schering-Plough act by inhibiting protein farnesyltransferase

Dec. 22, 2000

Recent patent covers new GnRH antagonists prepared by Merck scientists

Dec. 22, 2000

Preclinical trials with decitabine suggest potential in myelodysplastic syndrome, multiple myeloma

Dec. 22, 2000

Potent, selective proteasome compounds derived from belactosin

Dec. 22, 2000

York Medical changes name, reports pipeline progress

Dec. 22, 2000

Protein farnesyltransferase inhibitors useful for cancer therapy patented by BMS

Dec. 21, 2000

Faslodex highlighted at Breast Cancer Symposium as a novel approach to postmenopausal breast cancer

Dec. 21, 2000

Results from ongoing phase II trial of 9-NC in metastatic breast cancer reported in San Antonio

Dec. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...